$0.00

(%)
Live
Previous Close

$

Day Range

$ - $

Previous Day Range

$ - $

Market Cap

$1.4 billion USD

Day Vol.

Previous Day Vol.

Currency

USD

Primary Exchange

Nasdaq

Xencor Inc is a clinical-stage biopharmaceutical company based in the United States. It focuses on discovering and developing engineered monoclonal antibody and other protein therapeutics to treat severe and life-threatening diseases such with unmet ...


Community
  • 0 posts discussing
0

Watchers

0

Visitors


Recent News

6 analysts have shared their evaluations of Xencor (NASDAQ:XNCR) during the recent three months, expressing a mix of bullish and bearish perspectives. The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 1 4 1 0 0 Last 30D 0 1 0 0 0 1M Ago 1 0 0 0 0 2M Ago 0 0 0 0 0 3M Ago 0 3 1 0 0 In the assessment of 12-month price targets, analysts unveil insights for Xencor, presenting an average target of $33.0, a high estimate of $38.00, and a low estimate of $24.00. A decline of 17.91% from the prior average price target is evident in the current average. Deciphering Analyst Ratings: An In-Depth Analysis The analysis of recent analyst actions sheds light on the perception of Xencor by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets. Analyst Analyst Firm Action Taken Rating Current Price Target Prior Price Target David Nierengarten Wedbush Raises Outperform $36.00 $34.00 Kaveri Pohlman BTIG Lowers Buy $38.00 $56.00 Edward Tenthoff Piper Sandler Lowers Neutral $24.00 $37.00 Gregory Renza RBC Capital Maintains Outperform $32.00 - Etzer Darout BMO Capital Lowers Outperform $34.00 $38.00 David Nierengarten Wedbush Lowers Outperform $34.00 $36.00 Key Insights: Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Xencor. This information provides a snapshot of ...Full story available on Benzinga.com

Related tickers: XNCR, XNCR.

Read Full Article

Xencor (XNCR) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Related tickers: XNCR, FENC.

Read Full Article
Trending Tickers
CTMX

XNAS

$0.00
(%)
MIMO

XASE

$0.00
(%)
PRSO

XNAS

$0.00
(%)
QQQ

XNAS

$0.00
(%)
$0.00
(%)